CKAP4 and hepatocellular carcinoma: Taken together, these studies have showed that CKAP4 is expected to be a serological marker for HCC (Wang et al., 2019), lung cancer (Yanagita et al., 2018), PDAC (Kimura et al., 2019), and ESCC (Chen et al., 2018).